respiratory
COPD—beyond inhaler therapies with biologics
The emergence of biologic therapies represents one of the most significant advances in COPD management in more than 20 years. Understanding which patients may benefit, how these medicines work, and …
High risk triad: COPD, asthma and heart failure
The coexistence of asthma, COPD and heart failure represents a clinically complex and increasingly prevalent multimorbidity cluster, particularly in ageing populations. By Debbie Rigby, advanced practice pharmacist Learning outcomes After …
‘We cannot risk further delays’
Federal Government accused of “failing to commit” to a national RSV immunisation program after rejections to fund two vaccines, and protracted negotiations over a third The PBAC has rejected funding …
Dispensing during a pandemic
Dispensing has declined by 6%, with the biggest falls in respiratory and asthma-related scripts, new data reveals A new report released by Australian Institute of Health & Welfare (AIHW) has …
Respiratory Tract Infections
Pharmacy is often the first stop for patients with suspected respiratory tract infections; presenting an opportunity to provide antibiotic stewardship and self-care advice Respiratory tract infections (RTIs) are highly prevalent …